We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-10.63%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$349M
AUM Growth
-$49.7M
Cap. Flow
-$1.76M
Cap. Flow %
-0.5%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ASMB icon
Assembly Biosciences
ASMB
+$1.49M
2
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$268K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$65.7M 18.81%
3,931,818
– –
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$63.2M 18.11%
2,747,433
– –
KRON
3
DELISTED
Kronos Bio
KRON
$58M 16.6%
2,765,314
– –
PRAX icon
4
Praxis Precision Medicines
PRAX
$8.8B
$54.3M 15.57%
195,955
– –
DYN icon
5
Dyne Therapeutics
DYN
$4.24B
$48.1M 13.77%
2,960,046
– –
ALLO icon
6
Allogene Therapeutics
ALLO
$604M
$46.2M 13.24%
1,798,163
– –
OYST
7
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$7.58M 2.17%
640,070
-18,398
-3% -$268K
QTTB icon
8
Q32 Bio
QTTB
$452M
$6.07M 1.74%
42,825
– –
ASMB icon
9
Assembly Biosciences
ASMB
$513M
– –
-32,053
Closed -$1.49M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Vida Ventures Advisors held 9 positions worth $349M, down 12% from $399M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors's Q3 2021 filing shows 1 reduced and 1 closed positions. The largest sale was Assembly Biosciences, an estimated $1.49M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's biggest Q3 2021 reduction was Oyster Point Pharma, Inc. Common Stock, cutting an estimated $268K.
  • Vida Ventures Advisors fully exited Assembly Biosciences in Q3 2021, selling an estimated $1.49M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $349M portfolio in Q3 2021.
  • Vida Ventures Advisors opened 0 new positions and closed 1 in Q3 2021.
  • Vida Ventures Advisors's portfolio value fell 12% quarter-over-quarter to $349M.

Based on Vida Ventures Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.